Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-021033-30-FI
EUCTR2010-021033-30-FI
Active, not recruiting
Not Applicable

Evaluation of the effectiveness of vaccination with 2009 H1N1 vaccines during influenza season 2010-112009 H1N1-influenssarokotteiden tehokkuus influenssakaudella 2010-11 - Pandemiarokotuskampanjan jatkotutkimus

ational Institute for Health and Welfare0 sites3,000 target enrollmentJune 21, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInfluenza caused by the 2009 H1N1 influenza virus (swine influenza)MedDRA version: 12.1Level: LLTClassification code 10022001Term: Influenza (epidemic)
DrugsPandemrix, Influvac, Fluarix and other seasonal influenza vaccines used commercially in Finland

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Influenza caused by the 2009 H1N1 influenza virus (swine influenza)
Sponsor
ational Institute for Health and Welfare
Enrollment
3000
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
ational Institute for Health and Welfare

Eligibility Criteria

Inclusion Criteria

  • •Inclusion criteria for the interview follow\-up
  • •Participating in the study Evaluation of a vaccination campaign with A(H1N1\)v pandemic vaccines: a prospective cohort study” (AH1N1\-483\-09THL);
  • •Assigned to use the services of Tampere health care centre;
  • •Written consent for the interview follow\-up phase obtained by mail;
  • •Able to adhere to all protocol\-required study procedures without any special burden or risk, as judged by the participant himself/herself
  • •Inclusion criteria for the confirmation of 2009 H1N1 influenza cases
  • •Participating in the study interview follow\-up of the current study ‘Evaluation the effectiveness of vaccination with 2009 H1N1 vaccines during influenza season 2010\-11 (H1N1\-495\-10THL)
  • •Assigned to use the services of Tampere health care centre;
  • •Written informed consent for the confirmation phase obtained at the first study visit;
  • •Able to adhere to all protocol required study procedures without any special burden or risk, as judged by the investigator or designate.

Exclusion Criteria

  • •no specific exclusion criteria will be applied

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of efficacy and risks of vaccination for liver transplant recipientsiver transplant recipients
JPRN-UMIN000030485Kyoto University200
Completed
Phase 2
Study of HPV Vaccine adverse events and protection in patients with Juvenile Lupus and Juvenile Dermatomyositis
RBR-9ypbtfCoordenação de Aperfeiçoamento de Pessoal de Nível Superior
Completed
Not Applicable
assess the immunization compliance, common health problems of immunized under five children and perceived maternal barriers for immunization.
CTRI/2017/07/009130I310
Recruiting
Phase 2
Effects of vaccinium arctostaphylos fruit on cardiometabolic indices in hypertensive obese patientsCondition 1: Obesity. Condition 2: Hypertension.Obesity due to excess caloriesEssential (primary) hypertension
IRCT201710302288N12Vice Chancellor for Research, Research Institute for Islamic and Complementary Medicine100
Completed
Phase 2
Study on efficacy of Vaccinium arctostaphylos in the treatment of hypertensive hyperlipidemic type 2 diabetic patientsDiabetes mellitus.Non-insulin-dependent diabetes mellitus
IRCT201701282288N11Vice Chancellor for Research, ACECR Institute of Medicinal Plants150